Sanofi and our vaccines global vaccines business unit, Sanofi Pasteur, announced that the Strategic Advisory Group of Experts on Immunization (SAGE) has issued recommendations to the WHO on the use of its dengue vaccine.
WHO group backs Sanofi's vaccine in areas with high dengue rates https://t.co/KPavc03cZV
— Reuters Health (@Reuters_Health) April 15, 2016
The recommendations from the SAGE are based on the technical review of clinical data from 25 clinical studies conducted in 15 different endemic and non-endemic countries around the world, including more than 40,000 study participants.
— Sanofi Pasteur (@sanofipasteur) April 15, 2016
Elias Zerhouni, MD, President of global R&D, Sanofi said the recommendations “send a clear message to endemic countries about the strong public health benefit to be gained by introducing the dengue vaccine in integrated disease management efforts to combat their dengue burden.”
— DengueInfo (@DengueInfo) April 15, 2016
To learn more, please read the full press release: http://www.sanofipasteur.com/en/articles/Strategic-Advisory-Group-of-Experts-on-Immunization-Convened-by-the-World-Health-Organization-Recommends-Use-of-Sanofi-Pasteur-s-Dengue-Vaccine-in-Endemic-Countries.aspx